Leading policy-makers and scholars explain how market forces, deregulation, and consumer choice can work to improve health care for all Americans.


Letter to the Editor: Europe’s Drug Import Example
Panos Kavanos, Washington Post, 10-30-04

Europe has had reimportation of drugs – called "parallel trade" over there – for some time. This letter, by the author of a London School of Economics study on the economics of European reimportation, sets out the results of that study. The author found that most of the gains from reimportation went to the middlemen, not the consumers. In light of the example cited above of the $13 generic drug and the $15 shipping fee, it's well worth recalling that prices in Canada now will not be the same later if reimportation is adopted. Arbitrage is profitable, whether you're Ivan Boesky on Wall Street or the owner of a Canadian Internet pharmacy in Saskatoon.

Project FDA.
home   spotlight   commentary   research   events   news   about   contact   links   archives
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000